Доставка модифицированной мРНК в модели мыши инфаркта миокарда

Overview

This protocol presents a novel method for transiently upregulating a gene of interest using modified RNA (modRNA) after myocardial infarction in mice. It provides a standardized approach for delivering genes to the heart, which can also be applied to other models of cardiac injury.

Key Study Components

Area of Science

• Gene transfer
• Cardiac research
• Myocardial infarction

Background

• Modified RNA is an innovative technique for gene delivery.
• This method allows for transient expression of genes in the heart.
• It has potential applications beyond myocardial infarction, including ischemia reperfusion and transverse aortic constriction models.
• Currently, modified RNA is being utilized in various human clinical trials.

Purpose of Study

• To provide a clear protocol for gene delivery using modRNA.
• To enable accurate injection of modified RNA into the heart.
• To standardize the approach for researchers in the field.

Methods Used

• Delivery of modified RNA to the heart.
• Injection techniques demonstrated visually.
• Application of the method in various cardiac injury models.
• Comparison with existing gene transfer methods.

Main Results

• Successful transient upregulation of target genes in the heart.
• Demonstration of effective injection sites for modRNA.
• Potential for broader applications in cardiac research.
• Establishment of a standardized protocol for future studies.

Conclusions

• Modified RNA represents a promising tool for gene therapy in cardiac conditions.
• This protocol can enhance the reproducibility of gene delivery studies.
• Further research is needed to explore its full potential in clinical settings.

Frequently Asked Questions